INO-5412

N/A

Report date: 2026/03/19 20:00:18

Base Information

Drug NameINO-5412
Drug Alias NameINO-5401/INO-9012INO-5412INO5412
ClassificationBiologics
Mechanisms of ActionImmunostimulantsT lymphocytes stimulantsProstate-Specific Membrane Antigen modulators +[6] 
TargetsProstate-Specific Membrane AntigenTelomerase reverse transcriptaseWilms' Tumour 1 +[4] 
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes INO-5401Rocakinogene sifuplasmid
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInovio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesInovio Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A